Agenda

Registration and Refreshments

0815

Registration opens

Welcome and Opening remarks

0900

Opening remarks

Session 1: Plenary session

0910

Session 2: Patient involvement and engagement

0940

AMR

1000

Aspergillosis Patient perspective

Mrs Lisa McNeil - Aspergillosis Trust Mrs Lisa McNeil
Chair at
Aspergillosis Trust

Refreshment and Networking Break

1020

Refreshment break

Session 3: Haemato-oncology

10:45

Oxford Mycology Stewardship paper

1105

TBC

1125

RESPECT trial

1145

Q&A

Session 4: Sponsored Symposium

12:05

Sponsor Symposium

Lunch and Networking break

1230

Lunch break

1300

Poster viewings

Session 5: Sponsored Symposium

1330

Sponsor Symposium

Session 6: Meet the Pathogen

1400

Aspergillus resistance evolution

Dr Michael Bottery Dr Michael Bottery

1420

Mycovirus-Mediated Pathogenicity in Aspergillus fumigatus

1440

Mechanisms Promoting Candida Adaptation to the Mammalian Gastrointestinal Tract

1500

Q&A

Refreshment and Networking Break

1515

Refreshment break

Session 7: Guidelines

1535

Keynote: BSMM best practice guidelines

1555

MSG ECMM Endpoints consensus

1610

Do we need guidelines?

Professor Ali Omrani - Hamad Medical Corporation Professor Ali Omrani
Senior Consultant In Infectious Diseases at
Hamad Medical Corporation

1625

Panel discussion

Session 8: Clinical Conundra

1650

Presentation 1

1710

Presentation 2

1730

Presentation 3

1750

Q&A

Closing remarks

1800

Closing remarks

Registration and refreshments

0800

Registration open

Session 9: Free Paper Session

0830

Presentation 1

0840

Presentation 2

0850

Presentation 3

0900

Q&A

Session 10: Clinical Trials

0915

Interferon gamma in CPA

Dr Chris Kosmidis Dr Chris Kosmidis

0935

Ambition Trial - Advancing Crypto Meningitis

David Lawrence David Lawrence

0955

Q&A

Refreshment and Networking break

1010

Refreshment break

Session 11: Keynote

Chair | Professor Darius Armstrong-James Professor Darius Armstrong-James
Clinical Professor In Infectious Diseases And Medical Mycology at
Imperial College London

1030

Update on F1 AMR

Professor Darius Armstrong-James - Imperial College London Professor Darius Armstrong-James
Clinical Professor In Infectious Diseases And Medical Mycology at
Imperial College London

Session 12: Fungal IPC and AMR

Chair | Professor Darius Armstrong-James Professor Darius Armstrong-James
Clinical Professor In Infectious Diseases And Medical Mycology at
Imperial College London

1050

Fungal IPC

1110

Moulds in homes

1130

Q&A

Session 13: Sponsored expert talks - What's new?

1145

Presentation 1

1200

Presentation 2

Lunch and Networking Break

1215

Lunch break

Session 14: Fungal Communication

1300

ID:IOTS Podcast

1315

Lancet Microbe - Tips and Tricks

1330

Social media

Dr Neil Stone - University College London Dr Neil Stone
Consultant in Infectious Diseases and Microbiology at
University College London

1345

Q&A

Session 15: Drug Discovery and Development

1400

Challenges of getting a novel antifungal from the preclinical stage to market

1415

BARDA

1430

Challenges of getting a drug to market

1445

Presentation

1500

Q&A

Session 16: Who Priority Pathogen list - Where are we 5 years on and What does the future hold?

1515

Where are we and what does the future hold?

1540

Patient story

Mr Robert Purdie - MyCARE Foundation Mr Robert Purdie
President at
MyCARE Foundation

1600

Panel discussion

Closing Remarks

1615

Closing remarks, Poster and FungArt winner announcements

Dr Samir Agrawal - Barts Health NHS Trust & Blizard Institute Dr Samir Agrawal
Senior Lecturer and Honorary Consultant at
Barts Health NHS Trust & Blizard Institute

Meeting Close

1625

Meeting End